Inicio / Brain Health Research Program
Clinical Research Initiative | Planning Stage
Cognitive Health & Healthy Aging

Advancing the Science of Brain Health Through Measurable Outcomes

RX-O2 is developing a structured research initiative to investigate cognitive health in an aging population, including individuals experiencing changes in memory or thinking and adults with normal cognitive function.

Register Your Interest

Planned enrollment: 30 participant positions, subject to final protocol and eligibility review. Expressions of interest are welcome; this form does not enroll you in a clinical trial.

Why this matters

When someone you love begins to change

Perhaps a parent is taking longer to find words, becoming less confident with everyday tasks, or simply seeming different from the person you have always known. Perhaps you are doing well and want to contribute to research on maintaining cognitive function as we age.

We welcome inquiries from older adults across a spectrum of cognitive function, and from family members reaching out on their behalf. Final eligibility will be based on clinical screening and the study protocol, rather than this page alone.

The goal is to investigate measurable cognitive and functional outcomes through a structured scientific program. Participation requires commitment to screening, assessments, and follow-up.

Apply for Study Consideration
Research status: The protocol, oversight approvals, study procedures, and treatment allocation must be finalized before enrollment or research procedures begin. Expressing interest does not guarantee admission, treatment, or improvement.
A commitment to meaningful evidence

Scientific rigor is central to the program

Reliable findings require careful screening, consistent procedures, objective measurements, and transparent analysis. The program is being developed with those requirements at its foundation.

01

Clinical eligibility review

Admission requires review of prior medical records, health history, medications, relevant diagnoses, and hyperbaric contraindications.

02

Standardized cognitive testing

Baseline and follow-up assessments will use validated measures selected to evaluate cognition and meaningful day-to-day function.

03

Laboratory testing and imaging

Participants must be willing to complete protocol-required laboratory testing or imaging. Some expenses may be out of pocket and will be explained before consent.

04

Consistent treatment and follow-up

A defined schedule, attendance expectations, documented oxygen exposure, and follow-up visits are essential to interpretable results.

05

Comparison participants

Older adults with normal cognitive function are also encouraged to inquire. Comparison-group procedures and treatment allocation will follow the finalized protocol.

06

Blinded outcome assessment

The study design aims to use blinded outcome scoring, prespecified endpoints, and consistent analysis. Masking arrangements will be defined in the final protocol.

Designed for credible results. The analysis plan will address baseline differences, missing data, adherence, and adverse events. Blinded outcome assessment differs from a fully blinded trial. Comparing people with different baseline cognitive abilities alone cannot establish a treatment effect. Final controls and masking will be specified in the protocol. Findings are intended to support scientific reporting, but publication and positive results are not guaranteed.
Reach Out for More Information

Who should express interest?

Adults experiencing cognitive changes

  • Older adults with concerns about memory, attention, or processing speed
  • People noticing changes in everyday cognitive function
  • Families exploring possible research participation for a loved one
Inquire for Yourself or a Loved One

Adults with normal cognitive function

  • Older adults who report normal day-to-day cognitive function
  • People interested in contributing to a comparison cohort
  • Individuals willing to complete baseline and follow-up assessments
Ask About the Comparison Group

Cognitive changes deserve medical evaluation. HBOT is not an established treatment for preventing age-related cognitive decline. The study will investigate outcomes without promising benefit.

Clinical experience. Education. Safety.

Clinical and Educational Leadership

The program brings together clinical investigators and dedicated educational and safety oversight to support careful evaluation, participant understanding, and consistent research practices.

Marvin A. Borsand, D.O.

Marvin A. Borsand, D.O.

Clinical Investigator & Hyperbaric Physician

RX-O2’s Medical Director brings more than 30 years of patient care experience and has incorporated hyperbaric medicine into his practice since 2008. His background includes surgery, wound care, regenerative medicine, and participation in IRB-approved research through Cell Surgical Network.

Melanie Dooley, N.D.

Melonni Dooley, N.D.

Clinical Investigator & Hyperbaric Physician

Dr. Dooley is a licensed naturopathic physician providing hyperbaric consultations at RX-O2. A Sonoran University graduate with a master’s degree in plant biology, she brings research experience at Arizona State University, Mayo Clinic Scottsdale, and the USDA to her whole-person approach.

Alexander Borsand, M.D.

Alexander Borsand, M.D.

Education & Safety Oversight

RX-O2’s Clinic Safety Director and NHSA Educational Director supports research education, staff preparation, and hyperbaric safety oversight. An NHSA-certified trainer and lifestyle medicine diplomate, his role centers on education and operations. Medical evaluation and treatment remain with the licensed clinical investigators.

Connect With Our Research Team

What participation could involve

Admission is a clinical and research decision. Participants must be prepared for a structured program that extends beyond the treatment itself.

Screening includes previous medical records and relevant health history. Participation may include standardized cognitive testing, questionnaires, laboratory tests, imaging, and scheduled follow-up visits.

Participants assigned to an HBOT arm must be willing and able to follow the treatment schedule defined in the reviewed protocol. Session count, pressure, oxygen exposure, and follow-up intervals will be explained before consent.

Before making a commitment

  • Time requirements and study procedures will be explained.
  • Laboratory, imaging, treatment, and other out-of-pocket costs will be disclosed in advance.
  • Potential risks and uncertain benefits will be discussed.
  • Participation is voluntary and declining will not affect ordinary care.
  • Consent, privacy protections, and secure records handling will be addressed before research procedures.
Request Screening Information

Help answer important questions about cognitive aging

With a planned cohort of 30 participants, every inquiry is an opportunity to learn whether this program may be a fit. Older adults with cognitive concerns and those with normal cognitive function are encouraged to reach out.

Sign Up for Study Updates

An inquiry does not reserve a position. Enrollment depends on final study approvals, eligibility, and availability.

Research Interest Form

Contact us for yourself or a loved one. Please use your own contact details. Do not submit medical records, diagnoses, or detailed health information here. Our Glendale team will explain the appropriate secure screening process.

Submitting this form requests information only. Family inquiries do not replace the participant’s consent or legally authorized representative consent where applicable. MRI-style header imagery is illustrative and does not depict study results.